跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

11484281001

Roche

BM Blue POD可溶性底物

solution (ready-to-use), suitable for ELISA, pkg of 100 mL

别名:

3,3′,5,5′-四甲基联苯胺 溶液

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C16H20N2
CAS号:
54827-17-7
分子量:
240.34
Beilstein:
2808541
MDL编号:
MFCD00007748
UNSPSC代码:
12352204
PubChem化学物质编号:
329749453

描述

3,3′-5,5′-Tetramethylbenzidine (TMB)

质量水平

100

表单

solution (ready-to-use)

分子量

Mr 240.35

包装

pkg of 100 mL

制造商/商品名称

Roche

技术

ELISA: suitable

溶解性

water: soluble

储存温度

2-8°C

SMILES字符串

Cc1cc(cc(C)c1N)-c2cc(C)c(N)c(C)c2

InChI

1S/C16H20N2/c1-9-5-13(6-10(2)15(9)17)14-7-11(3)16(18)12(4)8-14/h5-8H,17-18H2,1-4H3

InChI key

UAIUNKRWKOVEES-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

应用

BM Blue POD可溶性底物非常适用于ELISA检测。它已被用于荧光素标记的毒蜥外泌肽-4结合试验。

产品规格

分子式：C16H20N2
颜色： 蓝色；反应终止后为黄色
评价方法： 光度测定法 (450 nm)

外形

即用型溶液

分析说明

吸附: 与TMB吸收光谱相同

其他说明

仅用于生命科学研究。不可用于诊断。

储存分类代码

12 - Non Combustible Liquids

WGK

WGK 1

闪点(°F)

No data available

闪点(°C)

No data available

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
71788900
65060700
63326500
56120500
54016600

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Jiandong Huo et al.
Nature structural & molecular biology, 27(9), 846-854 (2020-07-15)
The SARS-CoV-2 virus is more transmissible than previous coronaviruses and causes a more serious illness than influenza. The SARS-CoV-2 receptor binding domain (RBD) of the spike protein binds to the human angiotensin-converting enzyme 2 (ACE2) receptor as a prelude to
Kuan-Ying A Huang et al.
PLoS pathogens, 17(2), e1009352-e1009352 (2021-02-27)
Serological and plasmablast responses and plasmablast-derived IgG monoclonal antibodies (MAbs) have been analysed in three COVID-19 patients with different clinical severities. Potent humoral responses were detected within 3 weeks of onset of illness in all patients and the serological titre
Daming Zhou et al.
Nature structural & molecular biology, 27(10), 950-958 (2020-08-02)
The COVID-19 pandemic has had an unprecedented health and economic impact and there are currently no approved therapies. We have isolated an antibody, EY6A, from an individual convalescing from COVID-19 and have shown that it neutralizes SARS-CoV-2 and cross-reacts with
Sindhu Rajan et al.
Molecular metabolism, 4(4), 265-276 (2015-04-02)
Glucagon-like peptide 1 (GLP-1) enhances insulin secretion and protects β-cell mass. Diabetes therapies targeting the GLP-1 receptor (GLP-1R), expressed in numerous tissues, have diminished dose-response in patients with type 2 diabetes compared with healthy human controls. The aim of this

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门